Chris Freeman
Chief Commercial Officer at Guardant Health, Inc. (GH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $16.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 11SEC | GHGuardant Health, Inc. | Sell | 3,463125,516 held (−3%) | $167.38 | $580K | +0.1% |
| Aug 11SEC | GHGuardant Health, Inc. | Sell | 7,365118,151 held (−6%) | $168.79 | $1.2M | -0.8% |
| Aug 11SEC | GHGuardant Health, Inc. | Sell | 35,36482,787 held (−30%) | $169.63 | $6.0M | -1.3% |
| Aug 11SEC | GHGuardant Health, Inc. | Sell | 17,41365,374 held (−21%) | $170.24 | $3.0M | -1.6% |
| May 26SEC | GHGuardant Health, Inc. | Sell | 24,40660,034 held (−29%) | $118.67 | $2.9M | +41.1% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 47856,961 held (−1%) | $101.43 | $48K | +65.1% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 74456,217 held (−1%) | $102.31 | $76K | +63.7% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 37255,845 held (−1%) | $103.48 | $38K | +61.8% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 24455,601 held (−0%) | $104.10 | $25K | +60.9% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 22855,373 held (−0%) | $106.63 | $24K | +57.1% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 4,08451,289 held (−7%) | $101.40 | $414K | +65.2% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 11,96939,320 held (−23%) | $102.09 | $1.2M | +64.0% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 3,41435,906 held (−9%) | $103.25 | $352K | +62.2% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 6,55529,351 held (−18%) | $103.97 | $682K | +61.1% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 40028,951 held (−1%) | $105.99 | $42K | +58.0% |
| Dec 8SEC | GHGuardant Health, Inc. | Sell | 2,96425,987 held (−10%) | $106.71 | $316K | +56.9% |
- Sell
Chief Commercial Officer Chris Freeman sold $6.0M of GH at $169.63 — cuts the stake by 30%.
- Sell
Chief Commercial Officer Chris Freeman sold $2.9M of GH at $118.67 — cuts the stake by 29%.